Tag: Cancer: Misc.
Finances Affect Patient Decisions About Cancer Clinical Trials
Greater financial concern linked to lower self-efficacy and preparation for decision making
Patient Education Ups Willingness to Consider Clinical Trials
PRE-ACT increases knowledge, reduces attitudinal barriers; linked to greater patient satisfaction
CEO Challenge Spurs Workers to Adopt Healthy Practices
Increase in cancer screening, healthy eating, physical activity, tobacco cessation at one-year follow-up
Uptake of ‘Western Lifestyle’ Tied to Rising Cancer Rates
Lower-income countries have rising rates of same cancers common in high-income countries
FDA Approves Vistogard to Treat Chemotherapy Overdose
For overdose of the chemo drugs fluorouracil and capecitabine
Guidelines Developed for Perinatal Hematologic Cancers
Diagnostic procedures, chemotherapy and radiotherapy, maternal supportive care discussed
Variation in Prices of Cancer Drugs in High-Income Countries
Difference in drug price between highest-, lowest-priced countries varies between 28 and 388 percent
Safety Concerns Linked to Herbal Medicine Use in Cancer
Concerns include altered pharmacodynamics, direct toxic effects, increased chemosensitivity
November 2015 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2015. This roundup includes...
FDA Approves Empliciti for Multiple Myeloma
Monoclonal antibody works with another approved therapy to provide additional benefit
